Angiotech gets gynaecology study boost for anti-adhesion gel
This article was originally published in Clinica
Angiotech Pharmaceuticals says that its Adhibit adhesion prevention gel has produced encouraging results in a pivotal European trial that is testing the product's ability to reduce the incidence and severity of adhesions following laparoscopic surgery in a gynaecological population.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.